174.825 articles found

Evaluating Laryngeal Stability in Drug-Induced Parkinsonism Using Hilbert–Huang Transform and Chaos Dynamics: A Multi-Vowel Nonlinear Acoustic Framework for Differential Diagnosis

Lee A, Lee C.

Diagnostics (Basel, Switzerland) · 2026-09-30

Correction: Oliveira et al. Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology. Biomolecules 2020, 10, 945

Oliveira S, Dionísio P, Correia Guedes L, Gonçalves N, Coelho M, Rosa M, Amaral J, Ferreira J, Rodrigues C.

Biomolecules · 2026-09-30

AZP2006 in Parkinson's disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex.

Callizot N, Culley G, Flower G, Rouvière L, De Conto V, Wojcinski A, Botto C, Estrella C, Henriques A, Verwaerde P.

PLoS One · 2026-09-30

DOI: 10.1371/journal.pone.0359269PMID: 42814712

Peripheral <i>HMGB1</i> Downregulation Is Associated With the S100-IL-17 Axis in Parkinson's Disease: An Integrated Bulk and Single-Cell Transcriptomic Analysis.

Wang S, Shi H, Meng X, Zhu H.

Parkinsons Dis · 2026-09-30

DOI: 10.1155/padi/2128634PMID: 42820044

Resting-state cortical alpha frequency in Parkinson's disease and multiple system atrophy: associations with diagnosis, age, and symptom burden.

Chen D, Tang H, Pan Y, Sang H, Gu S, Wang X, Li K, Li F, Sun Y, Chen J, Sun W, Zhang J, Wang Z, Wei L.

Front Aging Neurosci · 2026-09-30

DOI: 10.3389/fnagi.2026.1928414PMID: 42876674

Electroacupuncture inhibits pyroptosis to improve motor function in an MPTP-induced mouse model of Parkinson's disease.

Ying YC, Dong YY, Chen GY, Wang X, Fan Q, Wu XC, Chen YL.

Front Aging Neurosci · 2026-09-30

DOI: 10.3389/fnagi.2026.1968826PMID: 42876728

Acupuncture is associated with lower accidental injury risk among patients with Parkinson's disease: a nationwide retrospective cohort study.

Chou HJ, Wang MJ, Lin SK.

Front Neurol · 2026-09-30

DOI: 10.3389/fneur.2026.1889885PMID: 42876775

A consistent vigor network in Parkinson's disease: a potential target for brain stimulation effects.

Kavian Z, Hajipour Sardouie S, Arasteh E, Mirian MS, Sreenivasan V, Yazdani M, McKeown MJ.

Front Hum Neurosci · 2026-09-30

DOI: 10.3389/fnhum.2026.1928519PMID: 42877181

Prediction of cognitive impairment in Parkinson's disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics.

Zhou Z, Liu J, Wang L, Lv H, Jiang W, Huang L, Zhang G, Ma R.

Front Aging Neurosci · 2026-09-30

DOI: 10.3389/fnagi.2026.1905374PMID: 42877199

Carotid atherosclerosis progression in patients with Parkinson's disease: a prospective cohort study.

Wang S, Yang N, Cheng H, Zhou Q.

Front Aging Neurosci · 2026-09-30

DOI: 10.3389/fnagi.2026.1928073PMID: 42877203

The gut-brain axis in Alzheimer's and Parkinson's diseases: a comparative perspective.

Upadhyay R, C C, Kar S, Sathyamoorthy S, Pitchaimuthu X, Sevanan M.

Front Microbiomes · 2026-09-30

DOI: 10.3389/frmbi.2026.1942228PMID: 42877500

NAD<sup>+</sup> signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives.

Wang T, Zhou X, Chen X.

Front Neurol · 2026-09-30

DOI: 10.3389/fneur.2026.1943801PMID: 42877680